Wave Life Sciences (WVE) Assets Average (2016 - 2025)
Wave Life Sciences' Assets Average history spans 11 years, with the latest figure at $439.9 million for Q4 2025.
- For Q4 2025, Assets Average rose 23.8% year-over-year to $439.9 million; the TTM value through Dec 2025 reached $439.9 million, up 23.8%, while the annual FY2025 figure was $495.4 million, 57.97% up from the prior year.
- Assets Average reached $439.9 million in Q4 2025 per WVE's latest filing, up from $246.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $439.9 million in Q4 2025 to a low of $163.9 million in Q4 2022.
- Average Assets Average over 5 years is $246.7 million, with a median of $231.0 million recorded in 2021.
- Peak YoY movement for Assets Average: plummeted 30.85% in 2021, then surged 49.67% in 2024.
- A 5-year view of Assets Average shows it stood at $203.8 million in 2021, then decreased by 19.54% to $163.9 million in 2022, then skyrocketed by 44.82% to $237.4 million in 2023, then soared by 49.67% to $355.4 million in 2024, then grew by 23.8% to $439.9 million in 2025.
- Per Business Quant, the three most recent readings for WVE's Assets Average are $439.9 million (Q4 2025), $246.9 million (Q3 2025), and $270.3 million (Q2 2025).